Dollars for Profs

Dig Into University Researchers' Outside Income and Conflicts of Interest

Published Dec. 6, 2019

This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.

Financial doc
Filing Type

Conflict of Interest

Institutions must file significant disclosures to the National Institutes of Health if they determine financial relationships could affect the design, conduct or reporting of the NIH-funded research. The NIH provided us with their entire financial conflict of interest database, with filings from 2012 through 2019.

Should you be removed from our database? Contact us at [email protected]. Read more below.

David Sinclair

Harvard Medical School, Department: Genetics

Should you be removed from our database? Contact us at [email protected]. Read more below.

Disclosed Conflict of Interest with

Life Biosciences (parent company) and Jumpstart Fertility (wholly owned subsidiary operated by Life)

Disclosed Value
Listed Reason
Equity Interest - Non-publicly traded entity ( e.g., stock, stock option, or other ownership interest)

This study is examining SIRT1 as a regulator of disease and aging in mice and cells. Jumpstart Fertility/Life Biosciences are looking to raise NAD+ levels to treat diseases, which would increase the activity of SIRT1. As such,Dr. Sinclair's financial interest could affect the design, conduct or reporting of the research.

Listed Research Project
SIRT1 as a regulator of health and lifespan of mammals

NA

Filed on November 06, 2017.

Tell us what you know about David Sinclair's disclosure

We're still reporting about conflicts of interest. Is there something you'd like to tell us about this disclosure?

Name Institution Type Company Disclosed Value
David Sinclair Harvard Medical School Conflict of Interest Cohbar, Inc. >$600,000
David Sinclair Harvard Medical School Conflict of Interest OvaScience >$600,000
David Sinclair Harvard Medical School Conflict of Interest Life Biosciences $250,000 - $299,999
David Sinclair Harvard Medical School Conflict of Interest Ovscience $40,000 - $59,999
David Sinclair Harvard Medical School Conflict of Interest GlaxoSmithKline $40,000 - $59,999
David Sinclair Harvard Medical School Conflict of Interest Senolytic Therapeutics $40,000 - $59,999
David Sinclair Harvard Medical School Conflict of Interest Ovscience $40,000 - $59,999
David Sinclair Harvard Medical School Conflict of Interest OvaScience $10,000 - $19,999
David Sinclair Harvard Medical School Conflict of Interest OvaScience $5,000 - $9,999
David Sinclair Harvard Medical School Conflict of Interest GlaxoSmithKline $5,000 - $9,999
David Sinclair Harvard Medical School Conflict of Interest Life Biosciences (parent company) and Jumpstart Fertility (wholly owned subsidiary operated by Life) $0 - $4,999
David Sinclair Harvard Medical School Conflict of Interest Jupiter Orphan Therapeutics Value cannot be readily determined
David Sinclair Harvard Medical School Conflict of Interest Liberty Biosecurity (wholly owned and operated subsidiary of EdenRoc Sciences) and EdenRoc Sciences Value cannot be readily determined
David Sinclair Harvard Medical School Conflict of Interest Metrobiotech East, LLC Value cannot be readily determined
David Sinclair Harvard Medical School Conflict of Interest EdenRoc Science Value cannot be readily determined
David Sinclair Harvard Medical School Conflict of Interest Life Biosciences Value cannot be readily determined
David Sinclair Harvard Medical School Conflict of Interest Spotlight Biosciences Inc. Value cannot be readily determined
David Sinclair Harvard Medical School Conflict of Interest Jumpstart Fertility (a subsidiary of Life Biosciences) Value cannot be readily determined
David Sinclair Harvard Medical School Conflict of Interest Liberty Biosecurity (wholly owned and operated subsidiary of EdenRoc Sciences) and EdenRoc Sciences Value cannot be readily determined
David Sinclair Harvard Medical School Conflict of Interest Senolytic Therapeutics Value cannot be readily determined
David Sinclair Harvard Medical School Conflict of Interest MetroBiotech Midatlantic, LLC Value cannot be readily determined
David Sinclair Harvard Medical School Conflict of Interest Life Biosciences (parent company) and Jupiter Orphan (wholly owned subsidiary operated by Life) Value cannot be readily determined
David Sinclair Harvard Medical School Conflict of Interest EdenRoc Sciences (parent company of Metro International Biotech and Liberty Biosecurity) Value cannot be readily determined
David Sinclair Harvard Medical School Conflict of Interest Iduna Therapeutics Value cannot be readily determined
If you see an error in the database or a reason we should not disclose a record, please contact us at [email protected] and we'll evaluate it on a case-by-case basis.
Sources: National Institutes of Health, public records requests filed at multiple public state universities

Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.

Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.

ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.

Close Comment Creative Commons Donate Email Facebook Mobile Phone Podcast Print RSS Search Search Twitter WhatsApp
Current site Current page